Immediate Impact

31 by Nobel laureates 10 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment
2024 Standout
3 intermediate papers

Works of Divis Khaira being referenced

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
2011
Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells
2010

Author Peers

Author Last Decade Papers Cites
Divis Khaira 384 86 369 237 7 762
Alessandra Metelli 362 46 371 302 11 870
Brian Riesenberg 338 86 304 314 16 816
Barbara Bodner 363 51 442 277 9 814
Diego Maritano 409 72 291 294 8 754
Yavar Shiravand 442 44 191 258 8 744
Antonia N. Policheni 290 39 274 321 11 691
Antony Letai 297 94 533 102 11 818
Mellissa J. Nixon 328 47 484 201 9 786
Jackie Thorburn 190 114 485 196 5 830
Samuel Wormald 405 52 363 267 8 789

All Works

Loading papers...

Rankless by CCL
2026